News
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...
A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency's top ...
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to his post, according to the Department of Health and Human Services ...
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma ...
The Food and Drug Administration restored a top vaccine regulator to his position at the agency just weeks after firing him.
Moderna announced layoffs affecting 10% of its workforce amid government and competitive challenges to its vaccine business ...
The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results